https://www.cancerresearchuk.org/about-cancer/treatment/drugs/vorasidenib
Vorasidenib (Voranigo) | Cancer information | Cancer Research UK
Vorasidenib is a treatment for some types of brain tumours. Find out how you have it, possible side effects and other important information.
cancer informationvorasidenibvoranigoresearchuk
https://www.hmpgloballearningnetwork.com/site/onc/quiz/vorasidenib-previously-untreated-patients-residual-or-recurrent-grade-2-idh-mutant
Vorasidenib for Previously Untreated Patients With Residual or Recurrent Grade 2 IDH-Mutant Glioma
The phase 3 INDIGO trial enrolled previously untreated patients with residual or recurrent grade 2 IDH-mutant glioma to receive either vorasidenib or placebo....
https://www.goodrx.com/voranigo/what-is
Voranigo (vorasidenib): Uses, Side Effects, Dosage & Reviews
Learn about Voranigo (vorasidenib) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
side effectsvoranigovorasidenibusesdosage
https://medlineplus.gov/druginfo/meds/a624055.html
Vorasidenib: MedlinePlus Drug Information
Vorasidenib: learn about side effects, dosage, special precautions, and more on MedlinePlus
vorasidenibmedlineplusdruginformation
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-vorasidenib-grade-2-astrocytoma-or-oligodendroglioma-susceptible-idh1-or-idh2-mutation
FDA approves vorasidenib for Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or...
On August 6, 2024, the Food and Drug Administration approved vorasidenib (Voranigo, Servier Pharmaceuticals LLC), an isocitrate dehydrogenase-1 (IDH1) and...
https://www.cigna.com/knowledge-center/hw/medications/vorasidenib-a624055
Vorasidenib | Cigna
Vorasidenib is used to treat adult and pediatric patients 12 years and older with certain types of astrocytoma or oligodendroglioma that have not improved with...
vorasidenibcigna